Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Treatment of Sarcopenia With Food for Special Medical Purposes in Rheumatologic Patients
Authors not listed
University of Bari · 2021
Abstract
Sarcopenia is defined as a pathological condition related to muscle strength and muscle mass reduction. It is caused by ageing (primary sarcopenia) and diseases associated with systemic inflammation (secondary sarcopenia). Systemic inflammation in rheumatological diseases often leads to physical inactivity, which is the main predictor of sarcopenia in this pathological condition. In these patients, the treatment of sarcopenia must necessarily include an appropriate nutritional approach, and the addition of oral supplements should be considered a complementary approach.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Anonymous. (2021). Treatment of Sarcopenia With Food for Special Medical Purposes in Rheumatologic Patients. <em>University of Bari</em>. https://clinicaltrials.gov/study/NCT07135388
Vancouver
Anonymous. Treatment of Sarcopenia With Food for Special Medical Purposes in Rheumatologic Patients. University of Bari. 2021.
BibTeX
@misc{anon2021Treatm,
title = {Treatment of Sarcopenia With Food for Special Medical Purposes in Rheumatologic Patients},
author = {Anonymous},
journal = {University of Bari},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
IRCCS Azienda Ospedaliero-Universitaria di Bologna 2022
Open access · US-GOV
Prognostic Model of Survival of Patients With Hepatocarcinoma and Sarcopenia Treated With Systemic Therapy
Yonsei University 2022
Open access · US-GOV
Association of Preoperative Sarcopenia and Intraoperative Hypotension in Patients Undergoing Minimally Invasive Pylorus Preserving Pancreaticoduodenectomy : Prospective Observational Study
Dokuz Eylul University 2023
Open access · US-GOV
Evaluation of Sarcopenia and Associated Factors in Patients With Lipedema
Acibadem University 2021
Open access · US-GOV
Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2025
Open access · US-GOV
Evaluation of HMB Supplementation on Motor Performance in Sarcopenic Patients
Institute of Oncology Ljubljana 2023
Open access · US-GOV